Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
New analgesic shows positive results in pre-clinical trial
, /in Product News /by panglobalDanish biotech Tetra Pharm Technologies announced promising results from a pre-clinical in vitro trial of its pain-relieving drug – TPT0301 – using a novel drug delivery technology. It was compared against more commonly used formulations for drug delivery in the oral cavity.
New Light Array Module advances phototropic organism research
, /in No Category, Product News /by panglobalBeckman Coulter Life Sciences has introduced a new Light Array Module (LAM) for the BioLector XT Microbioreactor which is set to advance research with a wide range of phototrophic organisms.
INTEGRA Biosciences’ pipettes help to combat prostate cancer
, /in E-News /by panglobalLynxDx, a Michigan diagnostics laboratory specializing in prostate cancer screening and risk prediction, acquired liquid handling solutions from INTEGRA Biosciences to streamline its sample preparation for high throughput COVID-19 testing. The lab is now in the process of moving these products over to prostate cancer screening, where they are helping to improve result accuracy and […]
Total bile acids 21 FS – now applicable for human stool samples
, /in Product News /by panglobalDiaSys successfully introduced Total bile acids 21 FS to determine total bile acids (TBA) in serum. Now, without altering the reagent composition and the highly sensitive enzymatic cycling method, the scope of the test has been expanded to detect TBA in human stool samples.
Neogap’s patented technology behind groundbreaking MS research
, /in E-News /by panglobalAntibodies against Epstein-Barr virus (EBV), a common virus that most people acquire early in life, are linked to multiple sclerosis (MS). This is shown in a study from the Karolinska Institutet, where technology from the biotech company Neogap Therapeutics has been used to map immune cells reactive to EBV and autoantigens related to MS.
AP 16 IF ELITE is an innovative, fast automated processor
, /in Product News /by panglobalAP 16 IF ELITE is an innovative, fast automated processor able to tun 16/20 IFA slides, it’s equipped with a sliding-sample barcode reader and a camera for the slide code reading.
C1q, C1 Inhibitor, C5 and Factor B assays for Nephelometry and Turbidimetry
, /in Product News /by panglobalTRIMERO Diagnostics offers C1q, C5, C1 (Esterase) Inhibitor and Factor B (C3 Proactivator) IVD CE marked assays on: Beckman Coulter’s IMMAGE® Immunochemical Systems Siemens Healthcare’s BN™ Series and Atellica® NEPH 630 nephelometers Clinical Chemistry Analyzers
Spacemarkers novel AI method identifies locations, interactions among genes in and around tumours
, /in E-News /by panglobalSpaceMarkers, a new machine learning software developed by researchers at the Johns Hopkins Convergence Institute and the Johns Hopkins Kimmel Cancer Center, can identify molecular interactions among distinct types of cells in and around a tumour.
New ‘pangenome’ offers more inclusive view of human genome
, /in E-News /by panglobalWhen it was launched in April 2003, the Human Genome Project helped revolutionize biomedical research by providing scientists a reference map that allowed them to analyze DNA sequences for genetic clues to the origins of a host of diseases.
Exothera partners with Quantoom Biosciences, launches new business unit for development and production of RNA
, /in E-News /by panglobalExothera has partnered with Quantoom Biosciences to gain access to Quantoom’s Nfinity technology, a continuous production platform for RNA. The partnership will enable Exothera to be the first CDMO in the world to offer this off-the-shelf process for the continuous production of RNA as a service. Continuous manufacturing of RNA can provide significant advantages in […]